Objective: The present review aimed to determine the effect of palm oil versus other oils on changes in body weight or Body Mass Index (BMI). Design: A systematic review was conducted. Studies were identified by database searching
Introduction

Description of the Condition
Obesity is an epidemic which is worsening in most parts of the world and a major health concern in Malaysia that recorded an increment for the last 20 years [1] [2] . Obesity is defined as a condition of excess adiposity and physiological state occurs in chronic imbalance of whole-body energy metabolism that caloric intake exceeding the energy expenditure [3] . Global Health Observatory Data by WHO also recorded a doubling in the prevalence of obesity from where in 2014, more than 1.9 billion adults aged 18 years and older were overweight, out of which over 600 million adults were obese [4] . Additionally, according to Snodgrass et al. (2016) adults are progressing from being overweight to being obese or morbidly obese at alarming rates [5] .
Evidences have shown the effect of increase in body weight or BMI are associated with the risk of chronic diseases such cardio vascular disease (CVD), type 2 diabetes mellitus (T2DM), hypertension, stroke, and some type of cancers [6] [7] [8] . Report from Malaysian National Health and Morbidity Survey (NHMS) shows an increasing trend in the percentage of overweight and obese individuals in the country from 1996 to [2002] [2003] where the prevalence of obesity was more than doubled and that the number of adults overweight increased more than 60% [9] . Changes in the life style and dietary fat consumption may result in endocrine disorders [10] . Studies have shown a strong positive association between saturated fat intake and the development of obesity and CVD [7] [8] [11] .
Saturated fats such as myristic, palmitic and lauric have been reported to cause disadvantages to health compared with the shorter chain saturated fats and unsaturated fatty acid such as oleic acid [12] [13] . Two types of oils that are produced by oil palms are palm kernel oil and palm oil, which nowadays are important in world trade. Palm oil which is obtained from the mesocarp of the palm fruit is composed of 50% saturated fatty acids, 40% monounsaturated fatty acids and 10% polyunsaturated fatty acids. The saturated fatty acid to unsaturated fatty acid ratio of palm oil is close to unity and it contains a high amount of the antioxidants, β-carotene, and vitamin E [13] .
Palm oil is claimed to have high saturated fat and its consumption supposedly raises the levels of blood cholesterol, thereby increasing the risk of coronary heart disease as well as obesity [14] . Based on individual studies, it is difficult to clearly determine if palm oil consumption is directly associated to overweight and/or obesity, as obesity is likely to be multifactorial, with factors such as other dietary habits, level of activity as well as lifestyle playing important parts.
Quality and Performance of Palm Oil
Food manufacturers prefer palm oil because of its nutritional benefits and versatility. The oil is highly structured to contain more than 95% neutral triacylglycerols (TAGs, or triglycerides) and less than 0.5% free fatty acids (FFAs) will determine their quality. The hydrolysis reaction occurs slowly in the presence of water but is catalysed by lipase enzymes as well as acid whereas oxidation is mediated by initiating free radicals to produce more radicals from fat molecules, which then readily combine with oxygen, a diradical (O-O), of air to give hydroperoxy radicals and then hydroperoxides. The role of fats in health and nutrition should be evaluated in the context of the digestion, absorption, and metabolism of lipids.
Triacylglycerols with long-chain fatty acids are mainly hydrolyzed by the pancreatic lipase to 2-monoacylglycerols or 2-monoglycerides and free fatty acids from positions −1 and −3 of the triglycerides as shown in Figure 1 . The ease or difficulty of absorption of these components will affect their subsequent metabolism and finally their role, if any, in cardiovascular diseases.
Fatty acids in the 2-monoacylglycerols are mainly unsaturated (87%), although overall 50% of the fatty acids in the three positions of triacylglycerols are saturated, a consequence of having the 1-and 3-positional fatty acids more highly saturated. There are two very important dietary consequences. First, the absorbed fatty acids are mainly mono-and di-unsaturated (87% for palm oil and up to 96% for palm olein), despite the relatively high saturation in the total glycerides.. Assuming that all the unsaturated fatty acids at the 1-and 3-positions in palm oil are preferentially absorbed while the saturated fatty acids from these same positions are excreted as salts, then only 8% of saturated fatty acids from the 2-position will be absorbed, an ideal situation to enhance the nutritional attribute of palm oil.
All oils and fats have the triacylglycerol or triglyceride structures shown below. Their differences were on the types of fatty acids (RCOOH) attached to the glycerol backbone in positions 1, 2, and 3 [16] .
There are many hypotheses linking palm oil and increase in weight or BMI.
This review aims at synthesising the available evidence reporting the effect of palm oil consumption with weight changes or BMI including obesity specifically or any other anthropometric measurements. The following search term was used "palm oil or related word variation" and "obesity or related word variation" (pre-obese, body mass index, body weight, waist circumference) or anthropometry wherever available. The references of included studies and systematic reviews were inspected for any additional studies.
Type of Studies
If we could find studies that assessed the effect of palm oil consumption to weight changes or BMI, particularly in large national or regional-level cohort studies, we would include these studies in the review, as well as any study that evaluated the effects of palm oil consumption to weight changes in human, such as randomized controlled trials, cluster-randomized controlled trials and quasirandomized controlled trials and all types of observational studies without any languages restriction. All studies that did not use palm oil as an exposure or any animal studies were excluded in this review.
We planned to include studies that use incidence or prevalence of obesity as Figure 2 and a table describing the characteristics of the included studies were constructed. The full texts of all potentially eligible articles were retrieved for independent review. Any disagreements were resolved by discussion. Articles deemed eligible went on to data extraction and quality assessment. Reviewers were not blinded to study authors.
Data Extraction and Management
Data extraction was performed according to a standardized data extraction form.
We developed a "Participants", "Exposure," "Comparator", "Outcomes" and duration of study, study location, study setting, withdrawals and study period.
Assessment of Risk of Bias in Included Studies
Risk of Bias Assessment
We used the Cochrane Risk of Bias tool to assess study quality. The risk of bias assessment was performed by two review authors. Any disagreements were resolved by another author. The risk of bias was made base on these domains:
• Random sequence generation.
• Allocation concealment.
• Blinding of participants and personnel.
• Blinding of outcome assessment.
• Incomplete outcome data.
• Selective outcome reporting.
• Other bias.
Each potential source of bias was graded as high, low or unclear. We used the specific evidence grading system developed by the GRADE group to assess the study quality [21] . 
Data Synthesis
We performed meta-analyses using Review Manager 5.3 (RevMan 2013) [22] . of Systematic Reviews of Interventions [26] . We chose three major outcomes to be included in our SOF table, which was generated using the GRADEpro software [27] . We expressed our results as MD or SMD. 
Results
A total of 7735 articles were retrieved from the database searches. Of these, 6099 unique articles were screened for title and abstracts. Following selection based on titles and abstracts, only 183 articles were eligible for full text-review. Searching clinicaltrials.gov yielded no additional studies. Cross-reference examination also yielded no additional relevant articles. Only one article was identified as a crossover trial i.e. study done by Tholstrup et al. 2011 [28] . The remaining 4 articles were randomised controlled trial. Therefore, a total of five articles were considered for quality assessment.
Excluded Studies
A total of 177 studies were excluded from the analysis. We excluded 70 studies that did not measure directly or indirectly the outcome of interest, 33 studies that did not use palm oil or its derivatives as the intervention, 27 animal or in-vitro studies, 46 conference and commentary papers. We also excluded 1 studies that only measured palm oil without any comparator.
Included Studies Characteristics of Included Studies
Out of the five included studies, four were RCTs, and one was quasi-randomised, cross-over study. Studies were conducted between 2005 to 2015 in Sweden, Denmark, Colombia and two studies were done in USA. All studies involved healthy adults of both sexes except study performed by Tholstrup et al. (2011) which included only adult men as their participants [28] . We defined the criterion as having been met if the study used palm oil in the intervention with a different list of comparisons. For example, study done by Kien 2005 , the intervention is on high palmitic acid compared to high oleic acid from sunflower oil [29] .
Whereas another four studies i.e. Tholstrup All studies either assessed weight and/or BMI as the primary outcomes, and none of the studies assessed incidence or prevalence of obesity. Detailed description of study characteristics is depicted in Table 1 .
Overall Search Results
Risk of Bias of the Included Studies
Only study done by Iggman 2014 was considered to have low risks of bias across all domains [30] . Risk of bias profiles of the remaining studies were unclear in most domains due to insufficient information provided by the authors. A detailed risk of bias assessment, displayed at the domain level and the study level, and are available in Figure 3 and Figure 4 respectively. Other bias
Was the use of Cross-over design appropriate?
Is it clear that the order of receiving treatment was randomized
Can it be assumed that the trial was not biased from carry-over effects?
Were data from the first period intervention available separately 0% 25% 50% 75% 100%
Low risk of bias Unclear risk of bias High risk of bias graded for high risk of bias and small study as shown in Figure 5 and Table A1 [32].
Analysis 2
Based on one study (Iggman 2014 Figure 6 and Table A4 .
Analysis 3
Based on one study (Kien 2005 ) there was no difference in BMI changes for both 
Study or Subgroup
Lucci, 2015
Total (95% CI)
Heterogeneity: Not applicable Test for overall effect: Z = 1.02 (P = 0.31) Figure 7 and 
Analysis 4
Study by Tholstrup (2011) as shown in Figure 8 revealed there was no difference in body weight changes between the groups that received palm oil and olive oil [mean difference −0.30, 95% CI (4.56 to 3.96)] with low quality of evidence, downgraded for unclear and high risk of bias and a single small study with wide CI (Table A2 ) [28] . 
Compared group: sunflower oil mixture: men
Kien 2014
Subtotal (95% CI)
Heterogeneity: Not applicable Test for overall effect: Z = 0.00 (P = 1.00)
Compared group: sunflower oil mixture: women
Kien 2014
Subtotal (95% CI)
Heterogeneity: Not applicable Test for overall effect: Z = 0.05 (P = 0.96)
Total (95% CI)
Heterogeneity: Chi² = 0.03, df = 2 (P = 0.98); I² = 0% Test for overall effect: Z = 0.14 (P = 0.89) Test for subgroup differences: Chi² = 0.03, df = 2 (P = 0.98), I² = 0% 
Analysis 5
Further study by Tholstrup 2011 showed there was no difference in body weight changes between the groups that received palm oil versus lard [mean difference 0.1 (95% CI; 4.14 to 4.34)] with low quality evidence (Figure 9 ), downgraded for unclear risk and high of bias and single small study with wide CI as shown in Table A3 [28]. Figure 10 was based on one study with 39 participants (Iggman 2014 ) which showed no difference in the waist changes circumference between the group that received palm oil and sunflower oil [mean difference −3.20, (95% CI −6.50 to 0.10)] with moderate quality of evidence, downgraded for unclear risk of bias as depicted in Table A4 [30].
Analysis 6
Discussion
The epidemic of obesity in Malaysia is in the increasing trend and mostly affected on children [9] . These overweight children are more likely to be overweight or obese in their adulthood and therefore are at greater risk of developing heart disease, diabetes, and other chronic ailments [33] . These situations however also indicated an emerging public health issue in Asia as well as in Malaysia. Developing countries including Malaysia are going through rapid nutrition transition from a large household of healthy traditional high-fibre, low-fat, and low-calorie diet shifting toward higher consumption of calorie-dense foods containing refined carbohydrates, fats, red meats, and low fibre [1] .
Summary of Main Results
We included five studies that evaluated body weight and BMI of the participants using palm oil. However, all studies were only represented by a small number of shown to achieve statistically significant association.
There is insufficient evidence to relate the association between dietary palm oil intake and obesity. There are no clear differences between palm oil and its comparators across all outcomes.
Overall Completeness and Applicability of Evidence
Through a comprehensive search strategy, five studies that matched our selection criteria in terms of population, intervention, comparison and outcomes. A total of 292 participants were assessed. We believe the studies gathered in this review, although small in number, represented the best available evidence to answer the question that we posed in conducting this review. Two studies were conducted in the US and another three studies in Sweden, Denmark and Colombia. These studies could limit the applicability of the findings to other parts of the world since we didn't have any studies that represented Asia. We were unable to undertake any subgroup analyses to further determine the applicability of the findings due to insufficient data.
Quality of the Evidence
There was overall low-quality evidence provided by a small number of studies.
The five included studies had low to high risk of bias in most domains except blinding, but the quality of evidence was downgraded by wide 95% CI in the estimates (see Appendix 2).
Potential Biases in the Review Process
We performed a comprehensive search from multiple databases with independent screening, selection and assessment of eligible studies. The main downgrading factor was imprecision, as most outcomes were contributed by single study.
Agreements and Disagreements with Other Studies or Reviews
Our findings are consistent with a published article by Mancini et al. that covered palm oil as the most widely used vegetable oil in the world [15] . The study stated that no clear evidence has been provided to unequivocally demonstrate the association of palm oil consumption and increase in cardiovascular risk.
However, to date, there was no study done directly for effect of dietary palm oil on obesity or adipose tissue cellularity in human.
Conclusions
There is a paucity of studies that compared the association of dietary palm oil intake and obesity, hence limiting the conclusions that we can reach. From the evidence gathered, it appeared unwarranted for any clear conclusion regarding the role of palm oil in contributing to obesity. 
Implications for Research
Other than insufficient research on this topic, this review has identified several issues in the included studies that should be considered by researchers undertaking future studies. Firstly, allocation concealment and blinding of participants and personnel were unclear, and this could have affected the reporting of subjective but clinically important outcomes such as weight reduction or body mass index. Future research should clearly emphasize on the method of randomization by using computerised randomization technique if possible. More focus should be given to the methods and selective reporting should be avoided by stating all the outcomes of interest and how were they measured. Further research is needed especially those using pure dietary palm oil versus comparator instead of using mixed palm oil vs comparators, designed in a manner that reflects actual palm oil intake in the population, and incorporating long-term measure of weight change as well as incidence of obesity or overweight as key outcomes. Future research should include key outcomes such as reduction in body weight or measurement of adipose tissues as well as body mass index or waist circumference. 
Effect of Intervention
